Proteomic Biomarker Analytics Market: By Application (Drug discovery, Research Application (cancer), Clinical Diagnostics, Others), By Technology (Mass Spectrometry, ELISA/Beads, Hybrid Multiplex, X-ray Crystallography, Electrophoresis, Microarray, Other), By End User (Academic and Research institutions, Pharma/biotech Companies, Clinical Diagnostic Laboratories, Other) and Geography

Purchase Option

$ 4400
$ 6600
$ 8900

Proteomic Biomarker Analytics Market size was valued at USD 24,983.8 million in 2023 and is poised to grow at a CAGR of 9.1% from 2024-2030. Proteomic biomarkers are proteins that detect the presence of certain illnesses or processes. They serve as quantitative markers of normal biological processes, pathogenic processes, or pharmacologic responses to therapeutic treatments such as tumour detection and treatment. This technology has the potential to replace Genomics and become the centre point of therapeutic applications. As we have discussed its potential application there is a huge opportunity for companies to tap in. Developments in Protein Biomarkers give a huge potential to the companies to expand in disease diagnostics etc.

The increasing incidence of chronic illnesses, growing demand for personalized medicines, increasing R&D expenditure and advancement of diagnostic techniques are driving the growth of the proteomics industry. The rising frequency of chronic illnesses such as cardiovascular diseases, respiratory diseases and especially cancer has increased the need for an effective diagnostic method. Furthermore, the increasing use of proteomics in drug discovery and development has greatly boosted market growth. The main restraints for this market are the lack of skilled workers who has expertise in proteomic research, cost and the huge requirement of resources, infrastructure needed in the research. There are regulatory norms which are also very stringent and acts as restraints. COVID-19 was a push of the Proteomic biomarker analytics market as most of the companies and research institutes invested in proteomic technology to find the relevant biomarkers for COVID-19.

Proteomic Biomarker Analytics Market Key Developments:
  • In January 2024, Vector Laboratories and Navinci Diagnostics announced a strategic collaboration to develop novel spatial proteomic tools for biomarker discovery, with product launches scheduled for 2025
  • In August 2022, Bruker Corporation launched the new nanoElute 2 nano-LC, of MetaboScape and TASQ 2023 software supporting fluxomics, and with latest advances in PaSER intelligent acquisition to enhance research in protein-protein interactions (PPIs) and metaproteomics applications.

Proteomic Biomarker Analytics Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

9.1%

Largest Market

North-America

Fastest Growing Market

Asia-Pacific

Proteomic Biomarker Analytics Market Dynamics

Drug discovery sees a trend of using proteomic technology, and finding of disease specific biomarkers signify the rise of usage of biomarkers in diagnostics. Major companies are investing huge in technologies in discovery of biomarkers such as Mass spectrometry and protein microarrays. The main research topic in this market is the early diagnostics of cancer. All these factors addition to advancement of healthcare gives a upside drive to the market. There are hundreds of clinical trials of protein biomarkers only for cancer, which indicates the involvement of companies in research. From this we can conclude that the demand for the new and existing Proteomic Biomarkers will be rising and this helps the market to expand. Companies like Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., GE Healthcare, Illumina, Inc., Merck, Thermo Fisher Scientific holds a substantial share of the Proteomic biomarker analytics market.

Proteomic Biomarker Analytics Market Segmentation

By Application

  • Drug discovery
  • Research Application (cancer)
  • Clinical Diagnostics
  • Other

By Technology

  • Mass Spectrometry
  • ELISA/Beads
  • Hybrid Multiplex
  • X-ray Crystallography
  • Electrophoresis
  • Microarray
  • Other

By End User

  • Academic and Research institutions
  • Pharma/biotech Companies
  • Clinical diagnostic laboratories
  • Other

Frequently Asked Questions

Proteomic biomarker analytics market size was valued at USD 24,983.8 million in 2023 and is poised to grow at a CAGR of 9.1% from 2024-2030.

The key players in the proteomic biomarker analytics market Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., GE Healthcare, Illumina, Inc., Merck, Thermo Fisher Scientific holds a substantial share of the Proteomic biomarker analytics market.

The increasing incidence of chronic illnesses mainly cancer, growing demand for personalized medicines, increasing R&D expenditure and advancement of diagnostic techniques are driving the growth of the proteomics industry.

Asia Pacific is estimated to be the fastest growing region for the Proteomic biomarker analytics market

North America has the largest share in the Proteomic biomarker analytics market.

Key Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030).
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies.
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market.
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market.
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenarios.
1.Executive Summary
2.Global Proteomic Biomarker Analytics Market Introduction 
2.1.Global Proteomic Biomarker Analytics Market  - Taxonomy
2.2.Global Proteomic Biomarker Analytics Market  - Definitions
2.2.1.Application
2.2.2.Technology
2.2.3.End User
2.2.4.Region
3.Global Proteomic Biomarker Analytics Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Proteomic Biomarker Analytics Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Proteomic Biomarker Analytics Market  By Application, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. Drug discovery
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Research Application (cancer)
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Clinical Diagnostics
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Other
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
6.Global Proteomic Biomarker Analytics Market  By Technology, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. Mass Spectrometry
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. ELISA/Beads
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Hybrid Multiplex
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. X-ray Crystallography
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
6.5. Electrophoresis
6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.5.3. Market Opportunity Analysis 
6.6. Microarray
6.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.6.3. Market Opportunity Analysis 
6.7. Other
6.7.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.7.3. Market Opportunity Analysis 
7.Global Proteomic Biomarker Analytics Market  By End User, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. Academic and Research institutions
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Pharma/biotech Companies
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Clinical diagnostic laboratories
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Other
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
8.Global Proteomic Biomarker Analytics Market  By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Asia Pacific (APAC)
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Middle East and Africa (MEA)
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Latin America
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9.North America Proteomic Biomarker Analytics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
9.1. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Drug discovery
9.1.2.Research Application (cancer)
9.1.3.Clinical Diagnostics
9.1.4.Other
9.2.  Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Mass Spectrometry
9.2.2.ELISA/Beads
9.2.3.Hybrid Multiplex
9.2.4.X-ray Crystallography
9.2.5.Electrophoresis
9.2.6.Microarray
9.2.7.Other
9.3.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Academic and Research institutions
9.3.2.Pharma/biotech Companies
9.3.3.Clinical diagnostic laboratories
9.3.4.Other
9.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1.United States of America (USA)
9.4.2.Canada
10.Europe Proteomic Biomarker Analytics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10.1. Application Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Drug discovery
10.1.2.Research Application (cancer)
10.1.3.Clinical Diagnostics
10.1.4.Other
10.2.  Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Mass Spectrometry
10.2.2.ELISA/Beads
10.2.3.Hybrid Multiplex
10.2.4.X-ray Crystallography
10.2.5.Electrophoresis
10.2.6.Microarray
10.2.7.Other
10.3.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Academic and Research institutions
10.3.2.Pharma/biotech Companies
10.3.3.Clinical diagnostic laboratories
10.3.4.Other
10.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Germany
10.4.2.France
10.4.3.Italy
10.4.4.United Kingdom (UK)
10.4.5.Spain
11.Asia Pacific (APAC) Proteomic Biomarker Analytics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11.1. Application Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Drug discovery
11.1.2.Research Application (cancer)
11.1.3.Clinical Diagnostics
11.1.4.Other
11.2.  Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Mass Spectrometry
11.2.2.ELISA/Beads
11.2.3.Hybrid Multiplex
11.2.4.X-ray Crystallography
11.2.5.Electrophoresis
11.2.6.Microarray
11.2.7.Other
11.3.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Academic and Research institutions
11.3.2.Pharma/biotech Companies
11.3.3.Clinical diagnostic laboratories
11.3.4.Other
11.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.China
11.4.2.India
11.4.3.Australia and New Zealand (ANZ)
11.4.4.Japan
11.4.5.Rest of APAC
12.Middle East and Africa (MEA) Proteomic Biomarker Analytics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12.1. Application Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Drug discovery
12.1.2.Research Application (cancer)
12.1.3.Clinical Diagnostics
12.1.4.Other
12.2.  Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Mass Spectrometry
12.2.2.ELISA/Beads
12.2.3.Hybrid Multiplex
12.2.4.X-ray Crystallography
12.2.5.Electrophoresis
12.2.6.Microarray
12.2.7.Other
12.3.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Academic and Research institutions
12.3.2.Pharma/biotech Companies
12.3.3.Clinical diagnostic laboratories
12.3.4.Other
12.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.GCC Countries
12.4.2.South Africa
12.4.3.Rest of MEA
13.Latin America Proteomic Biomarker Analytics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
13.1. Application Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Drug discovery
13.1.2.Research Application (cancer)
13.1.3.Clinical Diagnostics
13.1.4.Other
13.2.  Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Mass Spectrometry
13.2.2.ELISA/Beads
13.2.3.Hybrid Multiplex
13.2.4.X-ray Crystallography
13.2.5.Electrophoresis
13.2.6.Microarray
13.2.7.Other
13.3.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Academic and Research institutions
13.3.2.Pharma/biotech Companies
13.3.3.Clinical diagnostic laboratories
13.3.4.Other
13.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Brazil
13.4.2.Mexico
13.4.3.Rest of LA
14. Competition Landscape
14.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
14.2.1.Abbott Laboratories
14.2.2.Agilent/Dako
14.2.3.Basepair Biotechnologies
14.2.4.Beckman Coulter Diagnostics
14.2.5.Becton, Dickinson and Company
14.2.6.Bio-Rad Laboratories, Inc.
14.2.7.Bruker
14.2.8.C2N Diagnostics
14.2.9.Cepheid (Danaher)
14.2.10.Eve Technologies
14.2.11.Fluidic Analytics
14.2.12.Fujirebio
14.2.13.Hybrigenics Services
14.2.14.Luminex Corp
14.2.15.Nautilus Biotechnology
15. Research Methodology 
16. Appendix and Abbreviations 
  • Abbott Laboratories
  • Agilent/Dako
  • Basepair Biotechnologies
  • Beckman Coulter Diagnostics
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Bruker
  • C2N Diagnostics
  • Cepheid (Danaher)
  • Eve Technologies
  • Fluidic Analytics
  • Fujirebio
  • Hybrigenics Services
  • Luminex Corp
  • Nautilus Biotechnology
  • Nicoya
  • Olink
  • Qiagen
  • Quanterix
  • Roche Molecular Diagnostics
  • Siemens Healthineers
  • Somalogic
  • Thermo Fisher Scientific Inc

Adjacent Markets